The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: A case-control study

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Castillejo, Adela ^a   Mata Balaguer, Trinidad ^a   Guarinos, Carla ^a   Castillejo, María Isabel ^a   Martínez Cantó, Ana ^a   Barberá, Víctor Manuel ^a   Montenegro, Paola ^a   Ochoa, Enrique ^b   Lázaro, Rafael ^c   Guillén Ponce, Carmen ^a   Carrato, Alfredo ^a   Soto, José Luís ^a  

^a Elche University Hospital   (Spain)

^b Molecular Biopathology Department   (Spain)

^c La Plana Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN INT7G24A; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; PROTEIN SERINE THREONINE KINASE; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; ETHNICITY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POPULATION RISK; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; TUMOR LOCALIZATION; CASE CONTROL STUDY; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SEX FACTORS; SPAIN;

EID: 71549140359     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-406     Document Type: Article

References (24)

1. Siegel PM, Massagué J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003, 3(11):807-821. 10.1038/nrc1208, 14557817.
2. Bian Y, Kaklamani V, Reich J, Pasche B. TGF-beta signaling alterations in cancer. Cancer Treat Res 2003, 115:73-94. full_text, 12613193.
3. Massagué J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103(2):295-309. 10.1016/S0092-8674(00)00121-5, 11057902.
4. Pasche B, Kaklamani V, Hou N, Young T, Rademaker A, Peterlongo P, Ellis N, Offit K, Caldes T, Reiss M, Zheng T. TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. J Clin Oncol 2004, 22(4):756-758. 10.1200/JCO.2004.99.271, 14966109.
5. Skoglund J, Song B, Dalén J, Dedorson S, Edler D, Hjern F, Holm J, Lenander C, Lindforss U, Lundqvist N, Olivecrona H, Olsson L, Påhlman L, Rutegård J, Smedh K, Törnqvist A, Houlston RS, Lindblom A. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk. Clin Cancer Res 2007, 13(12):3748-3752. 10.1158/1078-0432.CCR-06-2865, 17575241.
6. Castillejo A, Mata-Balaguer T, Montenegro P, Ochoa E, Lázaro R, Martínez-Cantó A, Castillejo MI, Guarinos C, Barberá VM, Guillén-Ponce C, Carrato A, Soto JL. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study. BMC Cancer 2708189, 19538729.
7. Zhang HT, Fei QY, Chen F, Qi QY, Zou W, Wang JC, Zhang RM, Tao SH, Chen XF, Luo ZW. Mutational analysis of the transforming growth factor beta receptor type I gene in primary non-small cell lung cancer. Lung Cancer 2003, 40(3):281-287.
8. Zhang HT. Int7G24A variant of the TGFBR1 gene and cancer risk: a meta-analysis of three case-control studies. Lung Cancer 2005, 49(3):419-420. 10.1016/j.lungcan.2005.03.038, 15955593.
9. Chen T, Jackson C, Costello B, Singer N, Colligan B, Douglass L, Pemberton J, Deddens J, Graff JR, Carter JH. An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder. Int J Cancer 2004, 112(3):420-425. 10.1002/ijc.20419, 15382067.
10. Chen T, Jackson CR, Link A, Markey MP, Colligan BM, Douglass LE, Pemberton JO, Deddens JA, Graff JR, Carter JH. Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer. Clin Cancer Res 2006, 12(2):392-397. 10.1158/1078-0432.CCR-05-1518, 16428477.
11. Skoglund Lundin J, Vandrovcova J, Song B, Zhou X, Zelada-Hedman M, Werelius B, Houlston RS, Lindblom A. TGFBR1 variants TGFBR1*6A and Int7G24A are not associated with an increased familial colorectal cancer risk. Br J Cancer 2009, 100(10):1674-1679. 10.1038/sj.bjc.6605054, 19401691.
12. Loktionov A. Common gene polymorphisms, cancer progression and prognosis. Cancer Lett 2004, 208(1):1-33. 10.1016/j.canlet.2004.02.009, 15105042.
13. Slattery ML, Sweeney C, Murtaugh M, Ma KN, Wolff RK, Potter JD, Caan BJ, Samowitz W. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 2005, 14(12):2936-2942. 10.1158/1055-9965.EPI-05-0514, 16365013.
14. Buck MB, Knabbe C. TGF-beta signaling in breast cancer. Ann N Y Acad Sci 2006, 1089:119-126. 10.1196/annals.1386.024, 17261761.
15. Watson MA, Gay L, Stebbings WS, Speakman CT, Bingham SA, Loktionov A. Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis. Clin Sci (Lond) 2003, 104(5):537-545. 10.1042/CS20020329, 12529167.
16. Bae SJ, Kim JW, Kang H, Hwang SG, Oh D, Kim NK. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res 2008, 28(2B):1271-1276.
17. Press OA, Zhang W, Gordon MA, Yang D, Lurje G, Iqbal S, El-Khoueiry A, Lenz HJ. Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer. Cancer Res 2008, 68(8):3037-3042. 10.1158/0008-5472.CAN-07-2718, 18413774.
18. Wang JM, Irwin RW, Brinton RD. Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo. Proc Natl Acad Sci USA 2006, 103(45):16983-16988. 10.1073/pnas.0608128103, 1636565, 17077142.
19. Ruohola JK, Valve EM, Karkkainen MJ, Joukov V, Alitalo K, Härkönen PL. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol 1999, 149(1-2):29-40. 10.1016/S0303-7207(99)00003-9, 10375015.
20. Conzen SD. Minireview: nuclear receptors and breast cancer. Mol Endocrinol 2008, 22(10):2215-2228. 10.1210/me.2007-0421, 2582530, 18417735.
21. Marchini J, Cardon LR, Phillips MS, Donnelly P. The effects of human population structure on large genetic association studies. Nat Genet 2004, 36(5):512-517. 10.1038/ng1337, 15052271.
22. Pritchard JK, Cox NJ. The allelic architecture of human disease genes: common disease-common variant...or not?. Hum Mol Genet 2002, 11(20):2417-2423. 10.1093/hmg/11.20.2417, 12351577.
23. Markey MP, Graff J, Carter J, Chen T. Alternative splicing of a cancer-associated intronic variant of TGFBR1 in cancer cell lines. Proc Amer Assoc Cancer Research 2006, 47:2475.
24. Valle L, Serena-Acedo T, Liyanarachchi S, Hampel H, Comeras I, Li Z, Zeng Q, Zhang HT, Pennison MJ, Sadim M, Pasche B, Tanner SM, de la Chapelle A. Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer. Science 2008, 321(5894):1361-1365. 10.1126/science.1159397, 2672914, 18703712.